Wockhardt seems to be the stock which is likely to give you most bang for the buck. It is making base around 325-350 zone. Once it stays past 350 consistently, it has the steam to go up to levels of 450 but it is probably a bit of news driven. On declines, I would be much more confident and comfortable getting into Lupin and Sun Pharma as far as the pharma sector is concerned but overall, the pharma space will be a consistent performer in case the market continues to move higher.